11 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Neuropathic Pain Medications ... : Agent, Initiation ... Dose and Max Dosages ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... and Dosing #Management ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... phosphate binding agents ... Generally, the initial dose ... phosphate levels and doses ... Hyperphosphatemia #Dose
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Non-Opioid Analgesics - Agents ... and Dosing #Management ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Muscle Relaxants - Agents ... and Dosing #Management ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... Nerve #Blocks #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
and Nebulized Medications ... - Agents and Dosing ... Intranasal #Nebulized #Medications ... #Doses #Dosing ... #Table #PAMI
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANTAGONIST (ARB) DOSING ... an alternative agent ... Doses should be ... #Pharmacology #Conversion ... Switching #Equivalent #Table
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... 10 g QD (adjust dose ... Usual maintenance dose ... g QD; increase dose ... #pharmacology #table
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
use of adequate doses ... antihypertensive agents ... with previously stable ... parenchymal disease: CKD ... Differential #Diagnosis #indications